Triple therapy with low‐dose dapagliflozin plus saxagliptin versus dual therapy with each monocomponent, all added to metformin, in uncontrolled type 2 diabetes

AIM: To evaluate the efficacy and safety of triple therapy with low‐dose dapagliflozin plus saxagliptin added to metformin in uncontrolled type 2 diabetes. MATERIALS AND METHODS: This 24‐week, double‐blind trial (NCT02681094) randomized 883 patients (glycated haemoglobin [HbA1c] 7.5‐10.0%) on metfor...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Diabetes Obes Metab
Main Authors: Rosenstock, Julio, Perl, Shira, Johnsson, Eva, García‐Sánchez, Ricardo, Jacob, Stephan
Formato: Artigo
Idioma:Inglês
Publicado: Blackwell Publishing Ltd 2019
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6771748/
https://ncbi.nlm.nih.gov/pubmed/31144431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13795
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares